Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Association of CD31 and p53 With Survival of Ovarian Cancer Patients

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Neoadjuvant Chemotherapy Reduces the Treatment-free Interval After First-line Treatment in Patients With Advanced Ovarian Cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Long-term Survival After Surgical Treatment of Spinal Metastasis - The Predictive Role of Sex

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Improving Photoprotection and Implications for 25(OH)D Formation

    Publikation: Bidrag til tidsskriftReviewpeer review

  4. Lifetime UVR Dose and Skin Cancer Risk, Determined by Their Common Relation to Solar Lentigines

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Human papillomavirus genotype-specific risks for cervical intraepithelial lesions

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Expanding our understanding of ovarian cancer risk: the role of incomplete pregnancies

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Mucosal microRNAs relate to age and severity of disease in ulcerative colitis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Borderline ovarian tumors in Denmark 1997-2018: Time trends in incidence by histology, age and educational level

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

BACKGROUND/AIM: New markers for ovarian cancer are needed. This study aimed to examine the expression of tumour cell p53 and endothelial cell CD31 proteins and correlate them to clinicopathological factors.

PATIENTS AND METHODS: Expression of proteins was immunohistochemically assessed using tissue sections from 585-599 ovarian cancer patients from the Danish MALOVA study.

RESULTS: High CD31 expression was found in poorly differentiated tumours (p=0.0006), and high p53 expression was found in poorly differentiated cancers (p<0.0001), high clinical stage (p<0.0001), non-radical surgery (p<0.0001) and high serum CA-125 values (p<0.0001). CD31 expression showed no prognostic survival value, but high hazard ratios were found for patients with high p53 expression (HR=2.313, p<0.0001). An interaction was found between p53 and stage of cancer, suggesting a prognostic impact of p53 in low-stage, but not in advanced-stage cancer.

CONCLUSION: More than 5% of p53 tissue expression may predict shorter survival of ovarian cancer patients and may be useful for predicting the risk of disease progression in low-stage patients following primary surgery. CD31 has no strong prognostic value.

OriginalsprogEngelsk
TidsskriftAnticancer Research
Vol/bind39
Udgave nummer2
Sider (fra-til)567-576
Antal sider10
ISSN0250-7005
DOI
StatusUdgivet - feb. 2019

Bibliografisk note

Copyright© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

ID: 58605882